Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in BMY — Bristol Myers Squibb Co

CIK 1000275 TORONTO, A6
Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$696,907,326
+$32,262,057 QoQ
Shares Held
12,094,886
+10.4% QoQ
Ownership
0.592%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#26
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Jun 30, 2026
CallValue
$39,757,800
CallShares
690,000
PutValue
$121,002
PutShares
2,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. BMY ranks #8 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,358,401 $5,227,597,337
2 JNJ
Johnson & Johnson
 13,211,475 $3,355,318,297
3 ABBV
AbbVie Inc.
 8,163,806 $2,054,340,133
4 AZN
Astrazeneca PLC
 10,427,503 $1,977,263,112
5 MRK
Merck & Co., Inc.
 14,293,086 $1,836,661,547
6 AMGN
Amgen Inc
 4,328,785 $1,567,539,618
7 PFE
Pfizer Inc
 32,814,260 $790,167,373
8 BMY
Bristol Myers Squibb Co
This page 		12,094,886 $696,907,326

All Filings in BMY

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $696,907,326 12,094,886
2026-06-30 $39,757,800 690,000
2026-06-30 $121,002 2,100
2026-03-31 $63,682,500 1,050,000
2026-03-31 $127,365 2,100
2026-03-31 $664,645,269 10,958,702
2025-12-31 $1,370,076 25,400
2025-12-31 $681,989,576 12,643,485
2025-09-30 $451,000 10,000
2025-09-30 $902,000 20,000
2025-09-30 $579,278,871 12,844,321
2025-06-30 $654,546,427 14,140,126
2025-03-31 $815,948,302 13,378,395
2024-12-31 $813,101,521 14,375,911
2024-09-30 $559,378,259 10,811,331
2024-09-30 $24,576,500 475,000
2024-06-30 $283,946,212 6,837,135
2024-03-31 $428,782,070 7,906,732
2023-12-31 $350,368,943 6,828,473
2023-09-30 $5,223,600 90,000
2023-09-30 $366,723,179 6,318,456
2023-06-30 $415,426,165 6,496,109
2023-03-31 $407,803,398 5,883,760
2022-12-31 $507,195,907 7,049,283
2022-09-30 $4,620,850 65,000
2022-09-30 $422,919,379 5,949,070
2022-06-30 $32,532,500 422,500
2022-06-30 $459,726,883 5,970,479
2022-03-31 $434,472,334 5,949,231
2022-03-31 $160,213,214 2,193,800
2021-12-31 $470,351,871 7,543,735
2021-12-31 $68,946,630 1,105,800
2021-09-30 $357,943,523 6,049,409
2021-06-30 $482,219,018 7,216,687
2021-03-31 $402,535,558 6,376,296
2020-12-31 $460,572,493 7,424,996
2020-12-31 $23,261,250 375,000
2020-09-30 $22,608,750 375,000
2020-09-30 $396,476,741 6,576,161
2020-06-30 $22,050,000 375,000
2020-06-30 $342,104,687 5,818,107
2020-03-31 $29,681,550 532,500
2020-03-31 $315,757,004 5,664,819

Report a Problem

Category
Description
Email (optional, for follow-up)